Sirio Pharma (300791) Stock Overview

Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplements to customers worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; various nutraceutical gummies; probiotic products; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is headquartered in Shantou, China.